We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surveillance of Fungal Infections During Construction Activity

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00473252
First Posted: May 15, 2007
Last Update Posted: May 20, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital Inselspital, Berne
May 14, 2007
May 15, 2007
May 20, 2011
May 2006
July 2009   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00473252 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Surveillance of Fungal Infections During Construction Activity
Not Provided

Fungal infections in immunocompromised patients occuring during construction activities in hospitals have repeatedly been reported.

However, the question of a causal relation between construction activities and infections has never been addressed systematically and prospectively.

To answer this question, we will monitor our immunosuppressed patients' health status, as well as fine dust and aspergillus spore contents in the air during a three year construction activity period in our hospital.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Prevalent hemodialysis patients and incident renal transplant recipients in the Department of Nephrology and Hypertension, University Hospital Bern, Switzerland
Aspergillosis
Not Provided
  • Hemodialysis patients
  • Renal transplant patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
340
July 2009
July 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Kidney transplantation
  • Chronic hemodialysis treatment
Sexes Eligible for Study: All
16 Years and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT00473252
BE003
No
Not Provided
Not Provided
Andreas Pasch, Department of Nephrology and Hypertension, Inselspital, University Hospital Bern
University Hospital Inselspital, Berne
Not Provided
Study Director: Andreas Pasch, MD University of Bern
University Hospital Inselspital, Berne
May 2011